BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27417316)

  • 1. Proteomic analysis of drug-resistant Mycobacterium tuberculosis by one-dimensional gel electrophoresis and charge chromatography.
    Yari S; Hadizadeh Tasbiti A; Ghanei M; Shokrgozar MA; Fateh A; Mahdian R; Yari F; Bahrmand A
    Arch Microbiol; 2017 Jan; 199(1):9-15. PubMed ID: 27417316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant.
    Singh A; Gopinath K; Sharma P; Bisht D; Sharma P; Singh N; Singh S
    Indian J Med Res; 2015 Jan; 141(1):27-45. PubMed ID: 25857493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the proteomes of isoniazid-resistant Mycobacterium tuberculosis strains and isoniazid-susceptible strains].
    Jiang X; Gao F; Zhang WH; Hu ZY; Wang HH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):427-31. PubMed ID: 17673015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
    Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
    Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
    Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from high prevalence tuberculosis states in Mexico.
    Juarez-Eusebio DM; Munro-Rojas D; Muñiz-Salazar R; Laniado-Laborín R; Martinez-Guarneros JA; Flores-López CA; Zenteno-Cuevas R
    Infect Genet Evol; 2017 Nov; 55():384-391. PubMed ID: 27637930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel gene mtb192 is a candidate marker for the detection of multidrug-resistant Mycobacterium tuberculosis strains.
    Chen J; Jiang L; Su W; Zheng G; Hongmei X
    Gene; 2017 Aug; 626():264-268. PubMed ID: 28533124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of specific immunogenic antigens with potential diagnostic value in multi-drug resistant Mycobacterium tuberculosis inducing humoral immunity in MDR-TB patients.
    Hadizadeh Tasbiti A; Badmasti F; Siadat SD; Fateh A; Yari F; GHzanfari Jajin M; Yari S
    Infect Genet Evol; 2022 Sep; 103():105328. PubMed ID: 35788051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm.
    Simons SO; van der Laan T; Mulder A; van Ingen J; Rigouts L; Dekhuijzen PN; Boeree MJ; van Soolingen D
    Clin Microbiol Infect; 2014 Oct; 20(10):1015-20. PubMed ID: 24890253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Proteomic Analysis of Aminoglycosides Resistant and Susceptible Mycobacterium tuberculosis Clinical Isolates for Exploring Potential Drug Targets.
    Sharma D; Kumar B; Lata M; Joshi B; Venkatesan K; Shukla S; Bisht D
    PLoS One; 2015; 10(10):e0139414. PubMed ID: 26436944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis.
    Abbadi SH; Sameaa GA; Morlock G; Cooksey RC
    Int J Infect Dis; 2009 Nov; 13(6):673-8. PubMed ID: 19138546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypic characterization of multi-drug-resistant Mycobacterium tuberculosis isolates in Myanmar.
    Aye KS; Nakajima C; Yamaguchi T; Win MM; Shwe MM; Win AA; Lwin T; Nyunt WW; Ti T; Suzuki Y
    J Infect Chemother; 2016 Mar; 22(3):174-9. PubMed ID: 26806152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-drug resistant Mycobacterium tuberculosis complex genetic diversity and clues on recent transmission in Punjab, Pakistan.
    Yasmin M; Gomgnimbou MK; Siddiqui RT; Refrégier G; Sola C
    Infect Genet Evol; 2014 Oct; 27():6-14. PubMed ID: 24981519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of potential druggable targets among hypothetical proteins of extensively drug resistant Mycobacterium tuberculosis (XDR KZN 605) through subtractive genomics approach.
    Uddin R; Siddiqui QN; Azam SS; Saima B; Wadood A
    Eur J Pharm Sci; 2018 Mar; 114():13-23. PubMed ID: 29174549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in resistance mechanisms and diagnosis of non-first line anti-TB drugs.
    Liu Y; Wang BX; Liu ZY; Han Y; Tan YJ; Li XJ; Liu JX; Tan S; Zhang TY
    Yi Chuan; 2016 Oct; 38(10):928-939. PubMed ID: 27806934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of Mycobacterium tuberculosis isolates resistant to kanamycin and amikacin.
    Kumar B; Sharma D; Sharma P; Katoch VM; Venkatesan K; Bisht D
    J Proteomics; 2013 Dec; 94():68-77. PubMed ID: 24036035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.
    Kozhamkulov U; Akhmetova A; Rakhimova S; Belova E; Alenova A; Bismilda V; Chingissova L; Ismailov S; Ramanculov E; Momynaliev K
    Jpn J Infect Dis; 2011; 64(3):253-5. PubMed ID: 21617314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012.
    Yin QQ; Jiao WW; Li QJ; Xu F; Li JQ; Sun L; Li YJ; Huang HR; Shen AD
    BMC Microbiol; 2016 May; 16():85. PubMed ID: 27176471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda.
    Ssengooba W; Meehan CJ; Lukoye D; Kasule GW; Musisi K; Joloba ML; Cobelens FG; de Jong BC
    Infect Genet Evol; 2016 Jun; 40():8-16. PubMed ID: 26917365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Previous treatment in predicting drug-resistant tuberculosis in an area bordering East London, UK.
    Melzer M; Gupta N; Petersen I; Cook S; Hall B
    Int J Infect Dis; 2010 Aug; 14(8):e717-22. PubMed ID: 20542460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.